Your browser doesn't support javascript.
loading
Long-acting HIV fusion inhibitor albuvirtide combined with ritonavir-boosted lopinavir for HIV-1-infected patients after failing the first-line antiretroviral therapy: 48-week randomized, controlled, phase 3 non-inferiority TALENT study.
Su, Bin; Yao, Cheng; Zhao, Qing-Xia; Cai, Wei-Ping; Wang, Min; Lu, Hong-Zhou; Mu, Ting-Ting; Chen, Yuan-Yuan; Liu, Li; Wang, Hui; He, Yun; Zheng, Yu-Huang; Li, Ling-Hua; Chen, Jin-Feng; Yu, Jian-Hua; Zhu, Biao; Zhao, Min; Sun, Yong-Tao; Lun, Wen-Hui; Zhang, Yi-Hang; Wang, Hu; Xia, Wei; Sun, Li-Jun; Dai, Li-Li; Jiang, Tai-Yi; Wang, Mei-Xia; Zheng, Qing-Shan; Peng, Hai-Yan; Wang, Yao; Hu, Min; Liu, Xia; Lu, Rong-Jian; Hu, Jian-Hua; Sun, Cheng-Chen; Xing, Hui; Shao, Yi-Ming; Xie, Dong; Zhang, Tong; Zhang, Fu-Jie; Wu, Hao.
Afiliación
  • Su B; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Yao C; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China.
  • Zhao QX; Department of Infectious Diseases, Infectious Disease Hospital of Henan Province, Zhengzhou, Henan 450061, China.
  • Cai WP; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510060, China.
  • Wang M; Institute of HIV/AIDS, the First Hospital of Changsha, Changsha, Hunan 410005, China.
  • Lu HZ; Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
  • Mu TT; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Chen YY; Department of Infectious Diseases, Infectious Disease Hospital of Henan Province, Zhengzhou, Henan 450061, China.
  • Liu L; Department of Infectious Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
  • Wang H; Department of Infectious Diseases, National Clinical Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518112, China.
  • He Y; Department of Infectious Diseases, National Clinical Center for Infectious Diseases, Shenzhen Third People's Hospital, Shenzhen, Guangdong 518112, China.
  • Zheng YH; Department of Infectious Diseases, the Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China.
  • Li LH; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510060, China.
  • Chen JF; Infectious Disease Center, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong 510060, China.
  • Yu JH; Department of Infectious Diseases, Xixi Hospital of Hangzhou, Hangzhou, Zhejiang 310023, China.
  • Zhu B; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang 310003, China.
  • Zhao M; National Clinical Research Center for Infectious Diseases, the Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
  • Sun YT; Department of Infectious Diseases, Tangdu Hospital, the Fourth Military Medical University, Xi'an Shaanxi 710038, China.
  • Lun WH; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Zhang YH; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Wang H; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Xia W; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Sun LJ; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Dai LL; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Jiang TY; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Wang MX; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
  • Zheng QS; Center for Drug Clinical Research, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Peng HY; Beijing Co-CRO Medical Development Co., Ltd., Beijing 100711, China.
  • Wang Y; Beijing Co-CRO Medical Development Co., Ltd., Beijing 100711, China.
  • Hu M; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China.
  • Liu X; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China.
  • Lu RJ; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China.
  • Hu JH; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China.
  • Sun CC; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China.
  • Xing H; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Shao YM; State Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Xie D; Frontier Biotechnologies Inc., Nanjing, Jiangsu 211122, China. Electronic address: dxie@frontierbiotech.com.
  • Zhang T; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China. Electronic address: zt_doc@ccmu.edu.cn.
  • Zhang FJ; Clinical and Research Center of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address: treatment@chinaaids.cn.
  • Wu H; Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China. Electronic address: whdoc@ccmu.edu.cn.
J Infect ; 85(3): 334-363, 2022 09.
Article en En | MEDLINE | ID: mdl-35659547
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Infecciones por VIH / VIH-1 / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH / Inhibidores de Fusión de VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Infect Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Infecciones por VIH / VIH-1 / Inhibidores de la Proteasa del VIH / Fármacos Anti-VIH / Inhibidores de Fusión de VIH Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Infect Año: 2022 Tipo del documento: Article País de afiliación: China